Overview
- Bridgepoint and Triton are exploring bids in a formal process overseen by Rothschild, with indications of interest due this week.
- A potential deal is reported at about £1.5bn and would likely see Spire leave the FTSE‑250.
- Advent International and Bain Capital have contacted the adviser but are not expected to move forward.
- Spire’s shares closed at 178.2p after a 23% year-on-year slide, valuing the company just under £725m and implying any offer must come at a significant premium.
- The group runs nearly 40 hospitals and more than 50 clinics and treated over 1.3 million patients in 2024, while Mediclinic holds a 29.9% stake.